Clinical trial
Study in Adult Ph-positive ALL
NCT04688983 · Cardiff University, Other · Unknown status
Key facts
| NCT number | NCT04688983 |
|---|---|
| Title | Study in Adult Ph-positive ALL |
| Official title | An Open Label, 3-arm, Randomised Phase II Study to Compare the Safety and Efficacy of Ponatinib in Combination With Either Chemotherapy or Blinatumomab With Imatinib Plus Chemotherapy as Front-line Therapy for Patients Aged 55 Years and Over With Philadelphia Chromosome Positive (Ph+ or BCR-ABL+)… |
| Acronym | EWALL-Ph-03 |
| Lead sponsor | Cardiff University, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia, Adult |
| Intervention type | Drug |
| Interventions | Ponatinib, Blinatumomab, Imatinib |
| Enrollment | 180 |
| Start date | Jan 1, 2021 |
| Primary completion | Jan 1, 2024 |
| Completion | Jan 1, 2026 |
| First posted | Dec 30, 2020 |
| Last update posted | Dec 30, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: